HIV Treatment in a Conflict Setting: Outcomes and Experiences from Bukavu, Democratic Republic of the Congo

Overview

Journal PLoS Med

Specialty General Medicine

Date 2007 May 31

PMID 17535100

Citations 43

Authors

Heather Culbert

David Tu

Daniel P OBrien

Tom Ellman

Clair Mills

Nathan Ford

Tina Amisi

Keith Chan

Sarah Venis

Affiliations

Soon will be listed here.

Citing Articles

Outcome of HIV patients on ART during the war and siege in a tertiary hospital in Northern Ethiopia: a cross-sectional study.

Weledegebriel M, Nigusse A, Gebru T, Haftu H, Gebrehiwet T, Tsegay N Sci Rep. 2025; 15(1):6434.

PMID: 39984629 PMC: 11845719. DOI: 10.1038/s41598-025-90848-w.

Disruptions to HIV Prevention During Armed Conflict in Ukraine and Other Settings.

Nikitin B, Bromberg D, Ivasiy R, Madden L, Machavariani E, Dvoriak S Curr HIV/AIDS Rep. 2024; 22(1):10.

PMID: 39672977 PMC: 11823171. DOI: 10.1007/s11904-024-00716-x.

Factors associated with ART interruption during the COVID-19 crisis in Burundi (the EPIC community-based research program).

Niyongabo A, Villes V, Diagne R, Castro Avila J, Mutima J, Gakima D Sci Rep. 2024; 14(1):13187.

PMID: 38851798 PMC: 11162476. DOI: 10.1038/s41598-024-63805-2.

The impact of armed conflicts on HIV treatment outcomes in Sub-Saharan Africa: a systematic review and meta-analysis.

Kebede H, Gesesew H, Gebremedhin A, Ward P Confl Health. 2024; 18(1):40.

PMID: 38760792 PMC: 11100029. DOI: 10.1186/s13031-024-00591-8.

The Effect of Armed Conflict on Treatment Interruption, Its Outcome and Associated Factors Among Chronic Disease Patients in North East, Amhara, Ethiopia, 2022.

Mesfin B, Mersha Demise A, Shiferaw M, Gebreegziabher F, Girmaw F Patient Relat Outcome Meas. 2023; 14:243-251.

PMID: 37649898 PMC: 10463179. DOI: 10.2147/PROM.S388426.

References

Hankins C, Friedman S, Zafar T, Strathdee S . Transmission and prevention of HIV and sexually transmitted infections in war settings: implications for current and future armed conflicts. AIDS. 2002; 16(17):2245-52. DOI: 10.1097/00002030-200211220-00003. View

Mock N, Duale S, Brown L, Mathys E, Omaonaigh H, Abul-Husn N . Conflict and HIV: A framework for risk assessment to prevent HIV in conflict-affected settings in Africa. Emerg Themes Epidemiol. 2005; 1(1):6. PMC: 544944. DOI: 10.1186/1742-7622-1-6. View

Spiegel P . HIV/AIDS among conflict-affected and displaced populations: dispelling myths and taking action. Disasters. 2004; 28(3):322-39. DOI: 10.1111/j.0361-3666.2004.00261.x. View

Coghlan B, Brennan R, Ngoy P, Dofara D, Otto B, Clements M . Mortality in the Democratic Republic of Congo: a nationwide survey. Lancet. 2006; 367(9504):44-51. DOI: 10.1016/S0140-6736(06)67923-3. View

Ellman T, Culbert H, Torres-Feced V . Treatment of AIDS in conflict-affected settings: a failure of imagination. Lancet. 2005; 365(9456):278-80. DOI: 10.1016/S0140-6736(05)17802-7. View

Braitstein P, Brinkhof M, Dabis F, Schechter M, Boulle A, Miotti P . Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006; 367(9513):817-24. DOI: 10.1016/S0140-6736(06)68337-2. View

Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L . Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006; 367(9519):1335-42. DOI: 10.1016/S0140-6736(06)68580-2. View

Tassie J, Szumilin E, Calmy A, Goemaere E . Highly active antiretroviral therapy in resource-poor settings: the experience of Médecins Sans Frontières. AIDS. 2003; 17(13):1995-7. DOI: 10.1097/00002030-200309050-00023. View

Akileswaran C, Lurie M, Flanigan T, Mayer K . Lessons learned from use of highly active antiretroviral therapy in Africa. Clin Infect Dis. 2005; 41(3):376-85. DOI: 10.1086/431482. View

10.

Chaix M, Ekouevi D, Rouet F, Tonwe-Gold B, Viho I, Bequet L . Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire. J Infect Dis. 2006; 193(4):482-7. DOI: 10.1086/499966. View

11.

Etard J, Ndiaye I, Thierry-Mieg M, Ngom Gueye N, Gueye P, Laniece I . Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS. 2006; 20(8):1181-9. DOI: 10.1097/01.aids.0000226959.87471.01. View

12.

Calmy A, Pinoges L, Szumilin E, Zachariah R, Ford N, Ferradini L . Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. AIDS. 2006; 20(8):1163-9. DOI: 10.1097/01.aids.0000226957.79847.d6. View